ResisTrack scores whether a cancer cell line is likely to resist or respond to a given drug — pairing tumor genomics with drug chemistry, trained on 1.7M GDSC and DepMap measurements.
Pick any cell line and drug. ResisTrack pulls the cell line's omics profile and the drug's chemical descriptors automatically.
XGBoost estimates resistance probability against a tuned threshold to give the final call.
SHAP attributions, biomarkers, and drug targets show why — so a prediction is something you can reason about, not a black box.